These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32832427)

  • 1. Preoperative cervical cytology as a prognostic factor in endometrioid-type endometrial cancer: A single-center experience from Saudi Arabia.
    Abu-Zaid A; Alsabban M; Alomar O; Abuzaid M; Jamjoom MZ; Salem H; Al-Badawi IA
    Avicenna J Med; 2020; 10(3):111-117. PubMed ID: 32832427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Leukocytosis as a Prognostic Marker in Endometrioid-Type Endometrial Cancer: A Single-Center Experience from Saudi Arabia.
    Salem H; Abu-Zaid A; Aloman O; Abuzaid M; Alsabban M; Elhassan T; Salem A; Alyamani Y; Al-Badawi IA
    Gulf J Oncolog; 2020 Jan; 1(32):51-58. PubMed ID: 32342919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma.
    Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
    Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
    Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of cervical cytology in the diagnostic work-up of patients with endometrial cancer.
    Amkreutz LCM; Pijnenborg JMA; Joosten DWL; Mertens HJMM; Van Kuijk SMJ; Engelen MJA; Bergmans M; Nolting WE; Kruitwagen RFPM
    Cytopathology; 2018 Feb; 29(1):63-70. PubMed ID: 29280216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
    Banas T; Pitynski K; Okon K; Winiarska A
    BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
    Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
    Weinberg LE; Kunos CA; Zanotti KM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis.
    Abu-Zaid A; Alomar O; Abuzaid M; Baradwan S; Salem H; Al-Badawi IA
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():382-390. PubMed ID: 33529973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative leukocytosis correlates with unfavorable pathological and survival outcomes in endometrial carcinoma: A systematic review and meta-analysis.
    Abu-Zaid A; Alomar O; Baradwan S; Abuzaid M; Alshahrani MS; Allam HS; Alqarni SMS; Nazer A; Salem H; Al-Badawi IA
    Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():88-96. PubMed ID: 34298450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
    Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
    Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
    Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
    Heng S; Benjapibal M
    Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.
    Kahramanoglu I; Meydanli MM; Taranenka S; Ayhan A; Salman C; Sanci M; Demirkiran F; Ortac F; Haidopoulos D; Sukhin V; Kaidarova D; Stepanyan A; Farazaneh F; Aliyev S; Ulrikh E; Kurdiani D; Yalcin İ; Mavrichev S; Akilli H; Sarı ME; Pletnev A; Aslan K; Bese T; Kairbayev M; Vlachos D; Gultekin M
    Int J Gynecol Cancer; 2019 Oct; 29(8):1271-1279. PubMed ID: 31481453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.